ABEV Ambev posts narrow Q4 2025 earnings beat shares fall 204 percent on muted investor sentiment Biogen Inc BIIB Structural Headwinds Justify Avoidance Despite Current Profitability Does Atossa ATOS stock justify its valuation Q4 2025 Earnings Fall Short WHWK Whitehawk Therapeutics falls 336 as Q4 2025 EPS misses estimates by a wide 1164 percent margin Albemarle ALB Stock Value Opportunities Momentum Fading 20260427